Morpholino

MO2-cisha

ID
ZDB-MRPHLNO-151021-8
Name
MO2-cisha
Previous Names
  • cish.a ATG (1)
  • MO2-cish
Target
Sequence
5' - GCCTTCAACGCACAATATCATAAT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Translation-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-cisha
Phenotype
Phenotype resulting from MO2-cisha
Phenotype Fish Figures
blood island distended, abnormal WT + MO2-cisha Fig. 2 from Lewis et al., 2014
cell surface receptor signaling pathway via JAK-STAT increased occurrence, abnormal WT + MO2-cisha Fig. 5 from Lewis et al., 2014
common myeloid progenitor spi1b expression increased distribution, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
erythroblast increased amount, abnormal WT + MO2-cisha Fig. 3 from Lewis et al., 2014
erythroid lineage cell epor expression increased amount, abnormal WT + MO2-cisha Fig. 3 from Lewis et al., 2014
erythroid lineage cell gata1a expression increased amount, abnormal WT + MO2-cisha Fig. 3 from Lewis et al., 2014
granulocyte mmp9 expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
hematopoietic multipotent progenitor cell ikzf1 expression increased amount, abnormal WT + MO2-cisha Fig. 3 from Lewis et al., 2014
monocyte increased amount, abnormal WT + MO2-cisha Fig. 3 from Lewis et al., 2014
myeloid cell increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
myeloid cell lyz expression increased distribution, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
myeloid cell spi1b expression increased distribution, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
myeloid cell csf3r expression increased distribution, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
nucleate erythrocyte increased amount, abnormal WT + MO2-cisha Fig. 2 from Lewis et al., 2014
positive regulation of receptor signaling pathway via JAK-STAT increased occurrence, abnormal WT + MO2-cisha Fig. 5 from Lewis et al., 2014
T cell increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
thymus lymphocyte increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
thymus lymphocyte rag1 expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
thymus lymphocyte ikzf1 expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
thymus lymphocyte lck expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
thymus lymphocyte trac expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
whole organism trac expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
whole organism runx1 expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
whole organism lck expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
whole organism foxn1 expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
whole organism mmp9 expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
whole organism cisha expression increased amount, abnormal WT + MO2-cisha Fig. 5 from Lewis et al., 2014
whole organism ikzf1 expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
whole organism lyz expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
whole organism epor expression increased amount, abnormal WT + MO2-cisha Fig. 3 from Lewis et al., 2014
whole organism rag1 expression increased amount, abnormal WT + MO2-cisha Fig. 4 from Lewis et al., 2014
whole organism socs1a expression increased amount, abnormal WT + MO2-cisha Fig. 5 from Lewis et al., 2014
whole organism socs2 expression increased amount, abnormal WT + MO2-cisha Fig. 5 from Lewis et al., 2014
Phenotype of all Fish created by or utilizing MO2-cisha
Phenotype Fish Conditions Figures
myeloid cell csf3r expression increased distribution, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
positive regulation of receptor signaling pathway via JAK-STAT increased occurrence, abnormal WT + MO2-cisha control Fig. 5 from Lewis et al., 2014
whole organism rag1 expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
common myeloid progenitor spi1b expression increased distribution, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
thymus lymphocyte ikzf1 expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
erythroid lineage cell gata1a expression increased amount, abnormal WT + MO2-cisha control Fig. 3 from Lewis et al., 2014
cell surface receptor signaling pathway via JAK-STAT increased occurrence, abnormal WT + MO2-cisha control Fig. 5 from Lewis et al., 2014
thymus lymphocyte lck expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
blood island distended, abnormal WT + MO2-cisha standard conditions Fig. 2 from Lewis et al., 2014
whole organism epor expression increased amount, abnormal WT + MO2-cisha control Fig. 3 from Lewis et al., 2014
whole organism socs1a expression increased amount, abnormal WT + MO2-cisha control Fig. 5 from Lewis et al., 2014
whole organism runx1 expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
thymus lymphocyte trac expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
whole organism cisha expression increased amount, abnormal WT + MO2-cisha control Fig. 5 from Lewis et al., 2014
thymus lymphocyte increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
monocyte increased amount, abnormal WT + MO2-cisha control Fig. 3 from Lewis et al., 2014
whole organism lyz expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
whole organism ikzf1 expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
erythroblast increased amount, abnormal WT + MO2-cisha control Fig. 3 from Lewis et al., 2014
granulocyte mmp9 expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
whole organism foxn1 expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
whole organism socs2 expression increased amount, abnormal WT + MO2-cisha control Fig. 5 from Lewis et al., 2014
erythroid lineage cell epor expression increased amount, abnormal WT + MO2-cisha control Fig. 3 from Lewis et al., 2014
myeloid cell spi1b expression increased distribution, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
hematopoietic multipotent progenitor cell ikzf1 expression increased amount, abnormal WT + MO2-cisha control Fig. 3 from Lewis et al., 2014
whole organism trac expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
myeloid cell increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
whole organism lck expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
T cell increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
nucleate erythrocyte increased amount, abnormal WT + MO2-cisha standard conditions Fig. 2 from Lewis et al., 2014
thymus lymphocyte rag1 expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
whole organism mmp9 expression increased amount, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
myeloid cell lyz expression increased distribution, abnormal WT + MO2-cisha control Fig. 4 from Lewis et al., 2014
Citations